Redeye comments on Klaria’s announcement earlier today regarding a SEK9.7m directed convertible loan issuance and a SEK65.1m rights issue. While being highly dilutive measures, we view these developments as well-aligned with Klaria’s strategic shift from R&D to commercialization, anchored by the forthcoming launch of Sumatriptan Alginate Film.
LÄS MER